GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gilead Sciences Inc (NAS:GILD) » Definitions » Dividend Yield %

Gilead Sciences (Gilead Sciences) Dividend Yield %

: 4.55% (As of Today)
View and export this data going back to 1992. Start your Free Trial

As of today (2024-04-23), the Trailing Annual Dividend Yield of Gilead Sciences is 4.55%.

Good Sign:

Gilead Sciences Inc stock dividend yield is close to 10-year high.

The historical rank and industry rank for Gilead Sciences's Dividend Yield % or its related term are showing as below:

GILD' s Dividend Yield % Range Over the Past 10 Years
Min: 0.36   Med: 3.5   Max: 4.9
Current: 4.55

During the past 13 years, the highest Dividend Yield of Gilead Sciences was 4.90%. The lowest was 0.36%. And the median was 3.50%.

GILD's Dividend Yield % is ranked better than
87.17% of 499 companies
in the Drug Manufacturers industry
Industry Median: 1.83 vs GILD: 4.55

Gilead Sciences's Dividend Payout Ratio for the three months ended in Dec. 2023 was 0.44.

During the past 13 years, the highest Dividend Payout Ratio of Gilead Sciences was 0.78. The lowest was 0.11. And the median was 0.48.

As of today (2024-04-23), the Forward Dividend Yield % of Gilead Sciences is 4.64%.

Gilead Sciences's Dividends per Share for the three months ended in Dec. 2023 was $0.75.

During the past 12 months, Gilead Sciences's average Dividends Per Share Growth Rate was 2.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 3.30% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 5.50% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Gilead Sciences was 20.90% per year. The lowest was 3.30% per year. And the median was 8.50% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Gilead Sciences Dividend Yield % Historical Data

The historical data trend for Gilead Sciences's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gilead Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Yield %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.88 4.67 3.91 3.42 3.70

Gilead Sciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Dividend Yield % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.42 3.54 3.84 3.98 3.70

Competitive Comparison

For the Drug Manufacturers - General subindustry, Gilead Sciences's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gilead Sciences Dividend Yield % Distribution

For the Drug Manufacturers industry and Healthcare sector, Gilead Sciences's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Gilead Sciences's Dividend Yield % falls into.



Gilead Sciences Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Gilead Sciences Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 0.7702024-03-142024-03-152024-03-28Cash DividendquarterlyUSD:USD 1.000000
USD 0.7502023-12-142023-12-152023-12-28Cash DividendquarterlyUSD:USD 1.000000
USD 0.7502023-09-142023-09-152023-09-28Cash DividendquarterlyUSD:USD 1.000000
USD 0.7502023-06-142023-06-152023-06-29Cash DividendquarterlyUSD:USD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Gilead Sciences's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=3.02/66.96
=4.51 %

Current Share Price is $66.96.
Gilead Sciences's Dividends per Share for the trailing twelve months (TTM) ended in Today is $3.02.

Gilead Sciences's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=3.08/66.96
=4.60 %

Current Share Price is $66.96.
Gilead Sciences's Dividends per Share for the forward twelve months is calculated as $0.77 * 4 = $3.08.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gilead Sciences  (NAS:GILD) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Gilead Sciences Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Gilead Sciences's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Gilead Sciences (Gilead Sciences) Business Description

Address
333 Lakeside Drive, Foster, CA, USA, 94404
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Executives
Andrew D Dickinson officer: EVP, Chief Financial Officer 333 LAKESIDE DRIVE, FOSTER CITY CA 94404
Johanna Mercier officer: Chief Commercial Officer 333 LAKESIDE DRIVE, FOSTER CITY CA 94404
Merdad Parsey officer: Chief Medical Officer 333 LAKESIDE DRIVE, FOSTER CITY CA 94404
Sandra Patterson officer: SVP, Controllership 333 LAKESIDE DRIVE, FOSTER CITY CA 94404
Diane E. Wilfong officer: SVP, Controller & CAO 333 LAKESIDE DRIVE, FOSTER CITY CA 94404
Deborah H Telman officer: EVP, Corporate Affairs & GC 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Brett A Pletcher officer: EVP, Gen Counsel & Corp Sec 333 LAKESIDE DRIVE, FOSTER CITY X1 94404
Jeffrey Bluestone director C/O PROVENTION BIO, INC., P.O. BOX 666, OLDWICK NJ 08858
Anthony Welters director
Javier Rodriguez director 601 HAWAII ST., EL SEGUNDO CA 90245
John Francis Cogan director 2010 NORTH FIRST STREET, SUITE 310, SAN JOSE CA 95131
Gayle E Wilson director C/O GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE, FOSTER CITY CA 94404
Olsen Per Wold director C/O GILEAD SCIENCES, 333 LAKESIDE DRIVE, FOSTER CITY CA 94404
Sandra Horning director 333 LAKESIDE DRIVE, FOSTER CITY CA 94404
Richard James Whitley director UAB, CHB 303, 1600 7TH AVENUE SOUTH, BIRMINGHAM AL 35233-1711